Haryana Govt identifies 900-acre land for bulk drug park in Panipat


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Haryana Govt identifies 900-acre land for bulk drug park in Panipat
HSIIDC will be the authorised implementation agency, an Industry Advisory Council to be set up soon.

In an attempt to promote the manufacturing of APIs in India, the Haryana government has planned to set up a bulk drug/API park in Panipat. The State has chosen a 900-acre land behind the Panipat refinery. The government also desires to form an Industry Advisory Council soon to start the work on the proposed bulk drug park.

For a detailed discussion of the project and its benefits with industry stakeholders, the State Government organized a webinar in coordination with Pranav Gupta, Chairman, PHD Chamber, Haryana, accompanied by AK Singh, Principal Secretary, Industries and Commerce, Haryana, and Anurag Agrawal, Managing Director, Haryana State Industrial and Infrastructure Development Corporation (HSIIDC). It was attended by important representatives of the industry, primarily from North India such as Dinesh Dua, Chairman, Pharmexcil and BR Sikri, Chairman, FOPE, and Vice President, BDMA.

The HSIIDC has been authorized as the implementation agency and reportedly, it is planning to offer many profitable schemes to investors for the promotion of the API Park in Haryana.
Here are the names of a few schemes:
1) Capital Subsidy
2) Interest Subsidy
3) Refund of State GST
4) Employment Subsidy

Sikri informed, “The state government has identified the 900-acre land, of that 650 acres are for the proposed API park. The remaining land will be considered for other API manufacturers who do not fall in this catwhicy.”

Bringing to attention the benefits of the State whichh will work in favor of the industry stakeholders, he said, “The Haryana State records the third position in the country for ease of doing business. And with the best infrastructure available in the State, pharma companies will have the advantage of connectivity with two international and three domestic airports, along with 15 national highways passing the state as well as a well-connected railway network. These will ensure easy movement of pharma goods within the country as well as the export of pharma goods.”

He also mentioned, “It is assumed that appfulfilltely 30-35 pharma companies will be set up. However, the proposed committee will prepare a detailed project report, and based on the presented report, the DoP will scrutinize ,each application to ensure that the applicant/s can fulfill the eligibility criteria.”

According to the Central Government’s Scheme, bulk drug parks are going to be established in Andhra Pradesh, Telangana, and Himachal Pradesh. Many other States; mainly Uttar Pradesh, Gujarat and now Haryana, are also on the lookout to get approval from the government for Bulk Drug Parks.

Currently, around 150 pharma formulation units are located in the state.

Tags : #Haryana #DrugPark

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026